Hans Peter Schwarz
Viral inactivation
Baxter
Malaysia
Biography
Almost all of Baxter’s industry-leading plasma-based therapies have been impacted by Hans Peter Schwarz. His expertise in plasma fractionation, protein purification, viral inactivation, and other scientific disciplines has resulted in safer and more-effective therapies for hemophilia, immune disorders, and other conditions. He also has contributed to product development in other areas of bioscience, including recombinant proteins, biosurgery products, and vaccines.
Research Interest
Plasma fractionation, protein purification, viral inactivation, and other scientific disciplines
